Joseph E. Reece
Joseph E. Reece's purchase track record
How the stock did after each of Joseph E. Reece's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/26/2025 | CMP | $48K | +101.6% | +97.1% | +16.2% |
| 1/22/2024 | CMP | $106K | -36.0% | -40.5% | +14.7% |
| 11/9/2022 | VYX | $104K | +33.5% | +11.7% | +10.4% |
| 6/16/2022 | CMP | $167K | +21.3% | +29.8% | +6.2% |
| 5/11/2022 | CMP | $215K | -4.0% | -7.6% | -4.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Goldman Sachs cuts NCR Voyix price target to $8. Goldman Sachs maintained a Neutral rating on NCR Voyix but lowered its price target to $8. This action follows the company's recent Q2 2026 earnings call. The new target is below the current average analyst estimate of $12.96, reflecting a cautious outlook from the firm.
Transaction History
| CMP | ▲ Buy | Grant | 1,702 | $0 | 9/30/2026 | View on chart |
| CMP | ▲ Buy | Grant | 1,205 | $0 | 6/30/2026 | View on chart |
| CMP | ▲ Buy | Grant | 1,816 | $0 | 3/31/2026 | View on chart |
| CMP | ▲ Buy | Option Exercise | 22,322 | $0 | 3/5/2026 | View on chart |
| CMP | ▲ Buy | Grant | 2,260 | $0 | 12/31/2025 | View on chart |
| CMP | ▲ Buy | Grant | 2,312 | $0 | 9/30/2025 | View on chart |
| CMP | ▲ Buy | Grant | 2,209 | $0 | 6/30/2025 | View on chart |
| CMP | ▲ Buy | Grant | 2,209 | $0 | 6/30/2025 | View on chart |
| CMP | ▲ Buy | Grant | 4,777 | $0 | 3/31/2025 | View on chart |
| CMP | ▲ Buy | Open Market | 5,000 | $48K | 3/26/2025 | View on chart |
| CMP | ▲ Buy | Option Exercise | 10,659 | $0 | 3/5/2025 | View on chart |
| CMP | ▲ Buy | Grant | 3,945 | $0 | 12/31/2024 | View on chart |
| CMP | ▲ Buy | Grant | 3,692 | $0 | 9/30/2024 | View on chart |
| CMP | ▲ Buy | Grant | 4,296 | $0 | 6/28/2024 | View on chart |
| CMP | ▲ Buy | Grant | 2,706 | $0 | 3/31/2024 | View on chart |
| CMP | ▲ Buy | Grant | 372 | $0 | 3/20/2024 | View on chart |
| CMP | ▲ Buy | Option Exercise | 5,603 | $0 | 2/15/2024 | View on chart |
| CMP | ▲ Buy | Open Market | 5,000 | $106K | 1/22/2024 | View on chart |
| CMP | ▲ Buy | Grant | 1,654 | $0 | 12/31/2023 | View on chart |
| CMP | ▲ Buy | Grant | 181 | $0 | 12/20/2023 | View on chart |
| CMP | ▲ Buy | Grant | 1,543 | $0 | 9/30/2023 | View on chart |
| CMP | ▲ Buy | Grant | 161 | $0 | 9/20/2023 | View on chart |
| CMP | ▲ Buy | Option Exercise | 569 | $0 | 8/24/2023 | View on chart |
| CMP | ▲ Buy | Grant | 1,306 | $0 | 6/30/2023 | View on chart |
| CMP | ▲ Buy | Grant | 121 | $0 | 6/20/2023 | View on chart |
| VYX | ▲ Buy | Grant | 10,761 | $225K | 5/2/2023 | View on chart |
| VYX | ▲ Buy | Grant | 11,957 | $250K | 5/2/2023 | View on chart |
| CMP | ▲ Buy | Grant | 1,295 | $0 | 3/31/2023 | View on chart |
| CMP | ▲ Buy | Grant | 126 | $0 | 3/20/2023 | View on chart |
| CMP | ▲ Buy | Option Exercise | 2,324 | $0 | 2/14/2023 | View on chart |
| CMP | ▲ Buy | Grant | 1,052 | $0 | 12/30/2022 | View on chart |
| CMP | ▲ Buy | Grant | 74 | $0 | 12/20/2022 | View on chart |
| VYX | ▲ Buy | Open Market | 5,000 | $104K | 11/9/2022 | View on chart |
| VYX | ▲ Buy | Grant | 5,592 | $113K | 11/4/2022 | View on chart |
| VYX | ▲ Buy | Grant | 12,426 | $250K | 11/4/2022 | View on chart |
| CMP | ▲ Buy | Grant | 1,120 | $0 | 9/30/2022 | View on chart |
| CMP | ▲ Buy | Grant | 69 | $0 | 9/20/2022 | View on chart |
| CMP | ▲ Buy | Grant | 1,219 | $0 | 6/30/2022 | View on chart |
| CMP | ▲ Buy | Grant | 69 | $0 | 6/21/2022 | View on chart |
| CMP | ▲ Buy | Open Market | 3,000 | $102K | 6/16/2022 | View on chart |
| CMP | ▲ Buy | Open Market | 2,000 | $65K | 6/16/2022 | View on chart |
| CMP | ▲ Buy | Option Exercise | 2,423 | $0 | 5/18/2022 | View on chart |
| CMP | ▲ Buy | Open Market | 2,000 | $84K | 5/12/2022 | View on chart |
| CMP | ▲ Buy | Open Market | 3,000 | $131K | 5/11/2022 | View on chart |
| CMP | ▲ Buy | Grant | 687 | $0 | 3/31/2022 | View on chart |
| CMP | ▲ Buy | Grant | 39 | $0 | 3/21/2022 | View on chart |
| CMP | ▲ Buy | Grant | 796 | $0 | 12/31/2021 | View on chart |
| CMP | ▲ Buy | Grant | 38 | $0 | 12/20/2021 | View on chart |
| CMP | ▲ Buy | Grant | 631 | $0 | 9/30/2021 | View on chart |
| CMP | ▲ Buy | Grant | 148 | $0 | 9/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Compass Minerals Reports Q3 2026 Earnings
Compass Minerals released its third-quarter 2026 earnings call transcript. The company currently trades with a high trailing P/E ratio of 50.9, which is notably above the average analyst target price of $29.50. With the stock sitting near its support level of $29.03, investors are likely watching how the market reacts to the latest financial results.
Compass Minerals Reports Q3 2026 Earnings. Compass Minerals released its third-quarter 2026 earnings call transcript. The company currently trades with a high trailing P/E ratio of 50.9, which is notably above the average analyst target price of $29.50. With the stock sitting near its support level of $29.03, investors are likely watching how the market reacts to the latest financial results.